Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion type Assertion NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_head.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion description "[The engineered measles virus Edmonston strain MV-CEA has potent therapeutic efficacy against HB cell lines and xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_provenance.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion evidence source_evidence_literature NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_provenance.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion SIO_000772 23009685 NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_provenance.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion wasDerivedFrom befree-20150227 NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_provenance.
- NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_assertion wasGeneratedBy ECO_0000203 NP309275.RA3GLk6IdJnmn3tBIU7P2_vyTveYzUJIFJSMiB5pFxu6U130_provenance.